Back
Theriva Biologics Stock Price Chart
Sponsored
TOVX
Sponsored
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
35
TOVX
Theriva Biologics
Last Price:
1.38
Seasonality Move:
98.81%
7 Day Trial
ALL ACCESS PASS
$
7
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing slight selling pressure.
Theriva Biologics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.69 | Sell |
20-day SMA: | 1.65 | Sell |
50-day SMA: | 2.2 | Sell |
200-day SMA: | 7 | Sell |
8-day EMA: | 1.57 | Sell |
20-day EMA: | 1.69 | Sell |
50-day EMA: | 2.33 | Sell |
200-day EMA: | 6.4 | Sell |
Theriva Biologics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.15 | Sell |
Relative Strength Index (14 RSI): | 37.39 | Sell |
Chaikin Money Flow: | -34953 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.36 - 1.86) | Sell |
Bollinger Bands (100): | (1.83 - 5.83) | Sell |
Theriva Biologics Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Theriva Biologics Stock
Is Theriva Biologics Stock a Buy?
- Theriva Biologics share price is 1.36 while TOVX 8-day simple moving average is 1.69, which is a Sell signal.
- The stock price of TOVX is 1.36 while Theriva Biologics 20-day SMA is 1.65, which makes it a Sell.
- Theriva Biologics 50-day simple moving average is 2.20 while TOVX share price is 1.36, making it a Sell technically.
- TOVX stock price is 1.36 and Theriva Biologics 200-day simple moving average is 7.00, creating a Sell signal.
TOVX Technical Analysis vs Fundamental Analysis
Sell
35
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy or a Sell?
-
Theriva Biologics stock is rated a Sell
The current Theriva Biologics [TOVX] share price is $1.36. The Score for TOVX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Theriva Biologics Stock Info
Market Cap:
1.37M
Price in USD:
1.36
Share Volume:
81.56K
Theriva Biologics 52-Week Range
52-Week High:
17.11
52-Week Low:
1.24
Sell
35
Theriva Biologics (TOVX)
is a Sell
Theriva Biologics Share Price Forecast
-
What is the Theriva Biologics stock price today?
The Theriva Biologics stock price is 1.36 USD today. -
Will TOVX stock go up or go down?
Theriva Biologics> share price is forecast to RISE/FALL based on technical indicators -
Is Theriva Biologics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theriva Biologics is overvalued.
Is Theriva Biologics Stock a Buy?
- Theriva Biologics share price is 1.36 while TOVX 8-day exponential moving average is 1.57, which is a Sell signal.
- The stock price of TOVX is 1.36 while Theriva Biologics 20-day EMA is 1.69, which makes it a Sell.
- Theriva Biologics 50-day exponential moving average is 2.33 while TOVX share price is 1.36, making it a Sell technically.
- TOVX stock price is 1.36 and Theriva Biologics 200-day simple moving average is 6.40, creating a Sell signal.
Fundamental Analysis of Theriva Biologics
Is Theriva Biologics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
Technical Analysis of Theriva Biologics
Should I short Theriva Biologics stock?
- TOVX Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting Theriva Biologics is a Sell
- Theriva Biologics Relative Strength Index (RSI) is 37.39, which suggest Theriva Biologics is oversold
- The Bollinger Bands (25) for Theriva Biologics is (1.36 - 1.86), which suggest Theriva Biologics is a Sell
- The Bollinger Bands (100) for Theriva Biologics is (1.83 - 5.83), which suggest Theriva Biologics is a Sell
* Theriva Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.